Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012;7(8):e43307.
doi: 10.1371/journal.pone.0043307. Epub 2012 Aug 15.

Performance characteristics of the Cepheid Xpert MTB/RIF test in a tuberculosis prevalence survey

Affiliations

Performance characteristics of the Cepheid Xpert MTB/RIF test in a tuberculosis prevalence survey

Susan E Dorman et al. PLoS One. 2012.

Abstract

Background: Xpert MTB/RIF ("Xpert") is a molecular test for detection of Mycobacterium tuberculosis (MTB) in sputum. Performance characteristics have been established for its use during passive tuberculosis (TB) case detection in symptomatic TB suspects, but Xpert performance has not been assessed in other settings. Objectives were to determine Xpert performance and costs in the context of a TB prevalence survey.

Methodology/principal findings: This was a diagnostic sub-study of a TB prevalence survey conducted in gold mining companies in South Africa. Sputa (one per participant) were tested using smear microscopy, liquid culture (reference comparator), and Xpert. Costs were collected using an ingredients approach and analyzed using a public health program perspective. 6893 participants provided a sputum specimen. 187/6893 (2.7%) were positive for MTB in culture, 144/6893 (2.1%) were positive for MTB by Xpert, and 91/6893 (1.3%) were positive for acid fast bacilli by microsocopy. Sensitivity, specificity, positive predictive value, and negative predictive value for detection of MTB by Xpert were 62.6% (95% confidence interval [CI] 55.2, 69.5), 99.6% (99.4, 99.7), 81.3% (73.9, 87.3), and 98.9 (98.6, 98.8); agreement between Xpert and culture was 98.5% (98.2, 98.8). Sensitivity of microscopy was 17.6% (12.5, 23.9). When individuals with a history of TB treatment were excluded from the analysis, Xpert specificity was 99.8 (99.7, 99.9) and PPV was 90.6 (83.3, 95.4) for detection of MTB. For the testing scenario of 7000 specimens with 2.7% of specimens culture positive for MTB, costs were $165,690 for Xpert and $115,360 for the package of microscopy plus culture.

Conclusion: In the context of a TB prevalence survey, the Xpert diagnostic yield was substantially higher than that of microscopy yet lower than that of liquid culture. Xpert may be useful as a sole test for TB case detection in prevalence surveys, particularly in settings lacking capacity for liquid culture.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. Flow diagram of Xpert and MGIT testing results.

References

    1. Dye C, Bassili A, Bierrenbach AL, Broekmans JF, Chadha VK, et al. (2008) Measuring tuberculosis burden, trends, and the impact of control programmes. Lancet Infect Dis. 8: 233–243. - PubMed
    1. Glaziou P, van der Werf MJ, Onozaki I, Dye C, Borgdorff MW, et al. (2008) Tuberculosis prevalence surveys: rationale and cost. Int J Tuberc Lung Dis. 12: 1003–1008. - PubMed
    1. van der Werf MJ, Enarson DA, Borgdorff MW (2008) How to identify tuberculosis cases in a prevalence survey. Int J Tuberc Lung Dis. 12: 1255–1260. - PubMed
    1. World Health Organization. Tuberculosis prevalence surveys: a handbook. WHO/HTM/TB/2010.17. Available: www.who.int/tb/advisory_bodies/impact_measurement_taskforce/resources_do.... Accessed January 2, 2012.
    1. Fielding KL, Grant AD, Hayes RJ, Chaisson RE, Corbett EL, et al. (2011) Thibela TB: design and methods of a cluster randomised trial of the effect of community-wide isoniazid preventive therapy on tuberculosis amongst gold miners in South Africa. Contemp Clin Trials. 32: 382–392. - PubMed

Publication types